Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...
Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two ...
Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...
The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...
Turning the pandemic into potential, hundreds of biologists worldwide—including two researchers from Virginia Commonwealth ...
Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...
The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...
The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.
Robert F. Kennedy Jr. has been Health and Human Services secretary for all of a week, but he’s already pressing what looks like an anti-vaccine agenda. Mr. Kennedy never did disavow his vaccine ...